Hortapharm B.V.

From Wikipedia, the free encyclopedia
HortaPharm B.V.
IndustryHorticulture
Founded1990
FounderDavid Paul Watson
Headquarters
Amsterdam
,
Netherlands[1]
ProductsCannabis based medicine extracts

HortaPharm B.V. is a cannabis research and development business in the Netherlands.[2]

History[]

The business was founded by David Paul Watson in 1990. He was soon joined by David W. Pate and eventually Robert C. Clarke. They obtained the first license issued by the Dutch government to permit a Cannabis research facility in the Netherlands. In 1998, HortaPharm B.V. began partnering with GW Pharmaceuticals to develop Cannabis varieties for the manufacture of pharmaceuticals.[3][4]

Breeding[]

Using selective breeding and production control, HortaPharm created Cannabis strains that produce virtually single cannabinoids, approximately 98% tetrahydrocannabinol or cannabidiol, relative to the total of other cannabinoids present.[5]

References[]

  1. ^ "Archived copy". Archived from the original on 2013-10-05. Retrieved 2012-07-19.CS1 maint: archived copy as title (link)
  2. ^ The Inheritance of Chemical Phenotype in Cannabis sativa L. (HortaPharm B.V., 1075 VS, Amsterdam, The Netherlands)
  3. ^ Breen, Bill (2004-02-01). "Dr. Dope's Connection". Fast Company. Retrieved 2019-08-07.
  4. ^ "Details released of collaboration between GW Pharmaceuticals and Hortapharm medicinal cannabis". Archived from the original on 2012-07-30. Retrieved 2012-07-19.
  5. ^ Janet E. Joy; Stanley J. Watson Jr.; John A. Benson Jr. (1999), Marijuana and Medicine, National Academies Press, ISBN 9780309071550


Stub icon

This Cannabis-related article is a stub. You can help Wikipedia by .

  • v
  • t
Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by .

  • v
  • t
Retrieved from ""